Surgery – Miscellaneous – Methods
Patent
1997-11-12
1999-10-26
Yu, Mickey
Surgery
Miscellaneous
Methods
514 6, A61B 1900
Patent
active
059709855
ABSTRACT:
A method for treating systemic inflammatory response syndrome in a mammal by administering to the mammal a hemoglobin preparation after the mammal is diagnosed as suffering from systemic inflammatory response syndrome, wherein the systemic inflammatory response syndrome is a condition other than sepsis.
REFERENCES:
patent: 4529719 (1985-07-01), Tye
patent: 5295944 (1994-03-01), Teicher et al.
patent: 5296466 (1994-03-01), Kilbourn et al.
patent: 5334706 (1994-08-01), Przybelski
patent: 5344393 (1994-09-01), Roth et al.
patent: 5428007 (1995-06-01), Fischer et al.
patent: 5451205 (1995-09-01), Roth et al.
patent: 5480866 (1996-01-01), Bonaventura et al.
patent: 5510464 (1996-04-01), Przybelski
patent: 5614490 (1997-03-01), Przybelski
Conrad et al. "Effect of Red Cell Transfusion on Oxygen Consumption Following Fluid Resuscitation in Septic Shock" Circ Shock, 31(4): 419-29 (abstract) (Aug. 1990).
Nelson et al. "Synthesis and Properties of Polymerized, Diaspirin Cross-Linked Hemoglobins." Biomaterials, Artificial Cells, and Immobilization Biotechnology 20 (2-4): 253-8 (1992).
Malcolm et al. "Characterization of the Hemodynamic Response to Intravenous Diaspirin Crosslinked Hemoglobin Solution in Rats." Artif. Cells Blood Substit. Immobil. Biotechnol 22(1): 91-107 (Apr., 1994).
Slanetz et al., "Hemoglobin Blood Substitutes in Extended Preoperative Autologous Blood Donation: An Experimental Study," Surgery, vol. 115, No. 2, pp. 246-254, 1994.
Simoni et al., "Cytokines and PAF Release from Human Monocytes and Macrophages: Effect of Hemoglobin and Contaminants" Art. Cells, Blood Subs., and Immob. Biotech. 22(3): 525-534 (1994).
Schultz et al., "Diaspirin Crosslinked Hemoglobin (DCLHb) Attenuates Bacterial Translocation in Rats" Art. Cells, Blood Subs., and Immob. Biotech. 23(6): 647-664 (1995).
Otterbein et al., "Hemoglobin Provides Protection Against Lethal Endotoxemia in Rats: The Role of Heme Oxygenase-1," Am. J. Respir. Cell Mol. Biol., vol. 13, pp. 595-601, 1995.
Swan et al. "Pharmacologic Profile of Diaspirin Cross-Linked Hemoglobin in Hemodialysis Patients." Am. J. Kidney Dis. 26(6):918-23 (Dec. 1995).
Soltero et al. "Diaspirin Crosslinked Hemoglobin (DCLHb) May Be Beneficial in the Treatment of Septic Shock" Suppl to Shock; 3 (abstract #192) (1995).
Lin et al. "Development of a Model to Study Gastrointestinal Oxygen Utilization in Sepsis: Preliminary Results" Artif. Cells Blood Subs. Immobil. Biotech. 24(4):382 (abstract) (1996).
d'Almeida et al. "Influence of Sepsis on the Pharmacokinetics of Diaspirin Crosslinked Hemoglobin in Rats" Artif. Cells Blood Subs. Immobil Biotech. 24(4): 299 (abstract) (1996).
Law et al. "Diaspirin Crosslinked Hemoglobin Improves Perfusion in Sepsis" Artif Cells Blood Subs Immobil Biotech 24(4):377 (abstract) (1996).
Sielenkamper et al. "Efficacy of Diaspirin Crosslinked Hemoglogin, Fresh Blood and Old Blood Transfusion in Oxygen Supply-Dependent Septic Rats" Artif. Cells Blood Subs Immobil Biotech, 24(4):426 (abstract) (1996).
Sielenkamper et al. "Diaspirin Crosslinked Hemoglobin Improves Small Bowel Microvascular Blood Flow in Septic Rats" Int. Care Med.; 22(suppl 3): S440 (abstract #72) (1996).
d'Almeida et al. "Pharmacokinetics of Diaspirin Cross-Linked Hemoglobin in a Model of Sepsis in the Rat" Crit. Care Med. 24(1): A27 (abstract) (1996).
Mourelatos et al. "The Effects of Diaspirin Cross-Linked Hemoglobin in Sepsis." Shock 5(2): 141-148 (1996).
Alayash, "Hemoglobin and Tissue Oxidants: Physiological Implications and Protective Strategies," Artificial Cells, Blood Substitutues, and Immobilization Biotechnology, vol. 24, No. 4, p. 298, (abstract), 1996.
Garrioch et al., "The Hemodynamic Effects of Diaspirin Cross-Linked Hemoglobin (DCLHb) in the Operative Setting," Critical Care Medicine, vol. 24, No. 1, p. A39 (abstract), 1996.
Rhea et al., "Vasopressor Effects of Diaspirin Cross-Linked Hemoglobin (DCLHb) in Critically Ill Patients," Critical Care Medicine, vol. 24, No. 1, p. 3 (abstract), 1996.
Simoni et al., "Immunohistochemical Evaluation of Adhesion Molecules and Von Willebrand Factor Expression in Human Coronary Artery Endothelial Cells Incubated with Different Hemoglobin Solutions," Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, vol. 24, No. 4, p. 428 (abstract), 1996.
Simoni et al., "Modified Hb Solution, with Low Prooxidant Potential and Desired Pharmacological and Anti-Inflammatory Properties, Does Not Activate the Transcription Factor NF-kappa B in Human Vascular Endothelial Cells," Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, vol. 24, No. 4, p. 429, (abstract), 1996.
Vercellotti, "Vascular Responses to Hemoglobin Derived Iron: Potential Dangers and Cytoprotective Adaptations," Artificial Cells, Blood Substitutes, and Immobilization Biotechnology, vol. 24, No. 4, p. 451, (abstract), 1996.
Nelson et al. "Synthesis and Properties of Polymerized, Diaspirin Cross-Linked Hemoglobins." Biomaterials, Artificial Cells, and Immobilization Biotechnology 20 (2-4): 253-8 (1992).
Malcolm et al. "Characterization of the Hemodynamic Response to Intravenous Diaspirin Crosslinked Hemoglobin Solution in Rats." Artif. Cells Blood Substit. Immobil. Biotechnol 22(1): 91-107 (Apr., 1994).
Swan et al. "Pharmacologic Profile of Diaspirin Cross-Linked Hemoglobin in Hemodialysis Patients." Am. J. Kidney Dis. 26(6):918-23 (Dec. 1995).
Mourelatos et al. "The Effects of Diaspirin Cross-Linked Hemoglobin in Sepsis." Shock 5(2): 141-148 (1996).
Burhop Kenneth E.
Przybelski Robert J.
Baxter International Inc.
O'Hara Kelly
Yu Mickey
LandOfFree
Use of hemoglobin to treat systemic inflammatory response syndro does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of hemoglobin to treat systemic inflammatory response syndro, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of hemoglobin to treat systemic inflammatory response syndro will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-752493